Neovacs S.A.
Neovacs S.A. ALNEV.PA Peers
See (ALNEV.PA) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ALNEV.PA | $0.00 | -14.29% | 7.5K | N/A | -$221.36 | N/A |
| ARGX.BR | $515.60 | -0.96% | 31.5B | 35.76 | $14.42 | N/A |
| UCB.BR | $158.30 | +0.60% | 30.1B | 28.89 | $5.48 | +0.88% |
| TUB.BR | $124.40 | +0.48% | 5.5B | 61.58 | $2.02 | +0.84% |
| GLPG.AS | $25.64 | -0.70% | 1.7B | -9.39 | -$2.73 | N/A |
| PHARM.AS | $0.96 | +2.79% | 651.7M | -47.90 | -$0.02 | N/A |
| GTBP.PA | $280.50 | N/A | 626.7M | -4.10 | -$68.39 | N/A |
| MEDCL.PA | $16.87 | +0.48% | 557.9M | -15.48 | -$1.09 | N/A |
| VLA.PA | $2.84 | -0.98% | 474.7M | -5.07 | -$0.56 | N/A |
| IVA.PA | $2.94 | +3.16% | 390.1M | -0.95 | -$3.08 | N/A |
Stock Comparison
ALNEV.PA vs ARGX.BR Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ARGX.BR has a market cap of 31.5B. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ARGX.BR trades at $515.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ARGX.BR's P/E ratio is 35.76. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ARGX.BR's ROE of +0.17%. Regarding short-term risk, ALNEV.PA is more volatile compared to ARGX.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs UCB.BR Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, UCB.BR has a market cap of 30.1B. Regarding current trading prices, ALNEV.PA is priced at $0.00, while UCB.BR trades at $158.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas UCB.BR's P/E ratio is 28.89. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to UCB.BR's ROE of +0.11%. Regarding short-term risk, ALNEV.PA is more volatile compared to UCB.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs TUB.BR Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, TUB.BR has a market cap of 5.5B. Regarding current trading prices, ALNEV.PA is priced at $0.00, while TUB.BR trades at $124.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas TUB.BR's P/E ratio is 61.58. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to TUB.BR's ROE of +0.05%. Regarding short-term risk, ALNEV.PA is more volatile compared to TUB.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs GLPG.AS Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, GLPG.AS has a market cap of 1.7B. Regarding current trading prices, ALNEV.PA is priced at $0.00, while GLPG.AS trades at $25.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas GLPG.AS's P/E ratio is -9.39. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to GLPG.AS's ROE of -0.06%. Regarding short-term risk, ALNEV.PA is more volatile compared to GLPG.AS. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs PHARM.AS Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, PHARM.AS has a market cap of 651.7M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while PHARM.AS trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas PHARM.AS's P/E ratio is -47.90. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to PHARM.AS's ROE of -0.06%. Regarding short-term risk, ALNEV.PA is more volatile compared to PHARM.AS. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs GTBP.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, GTBP.PA has a market cap of 626.7M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while GTBP.PA trades at $280.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas GTBP.PA's P/E ratio is -4.10. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to GTBP.PA's ROE of -4.68%. Regarding short-term risk, ALNEV.PA is less volatile compared to GTBP.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs MEDCL.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, MEDCL.PA has a market cap of 557.9M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while MEDCL.PA trades at $16.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas MEDCL.PA's P/E ratio is -15.48. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to MEDCL.PA's ROE of +0.66%. Regarding short-term risk, ALNEV.PA is more volatile compared to MEDCL.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs VLA.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, VLA.PA has a market cap of 474.7M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while VLA.PA trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas VLA.PA's P/E ratio is -5.07. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to VLA.PA's ROE of -0.43%. Regarding short-term risk, ALNEV.PA is more volatile compared to VLA.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs IVA.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, IVA.PA has a market cap of 390.1M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while IVA.PA trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas IVA.PA's P/E ratio is -0.95. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to IVA.PA's ROE of +1.98%. Regarding short-term risk, ALNEV.PA is more volatile compared to IVA.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ABVX.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ABVX.PA has a market cap of 328M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ABVX.PA trades at $5.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ABVX.PA's P/E ratio is -1.85. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ABVX.PA's ROE of -2.11%. Regarding short-term risk, ALNEV.PA is more volatile compared to ABVX.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs DBV.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, DBV.PA has a market cap of 214.8M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while DBV.PA trades at $1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas DBV.PA's P/E ratio is -1.64. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to DBV.PA's ROE of -2.68%. Regarding short-term risk, ALNEV.PA is more volatile compared to DBV.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ORY.MC Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ORY.MC has a market cap of 211.1M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ORY.MC trades at $2.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ORY.MC's P/E ratio is -38.93. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ORY.MC's ROE of -0.04%. Regarding short-term risk, ALNEV.PA is more volatile compared to ORY.MC. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs GNFT.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, GNFT.PA has a market cap of 192M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while GNFT.PA trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas GNFT.PA's P/E ratio is 128.53. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to GNFT.PA's ROE of +0.02%. Regarding short-term risk, ALNEV.PA is more volatile compared to GNFT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ONWD.BR Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ONWD.BR has a market cap of 188M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ONWD.BR trades at $4.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ONWD.BR's P/E ratio is -5.26. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ONWD.BR's ROE of -1.08%. Regarding short-term risk, ALNEV.PA is more volatile compared to ONWD.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs IPH.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, IPH.PA has a market cap of 176.9M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while IPH.PA trades at $1.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas IPH.PA's P/E ratio is -3.15. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to IPH.PA's ROE of -2.63%. Regarding short-term risk, ALNEV.PA is more volatile compared to IPH.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs NANO.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, NANO.PA has a market cap of 162.5M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while NANO.PA trades at $3.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas NANO.PA's P/E ratio is -2.40. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to NANO.PA's ROE of +0.77%. Regarding short-term risk, ALNEV.PA is more volatile compared to NANO.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs HYL.BR Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, HYL.BR has a market cap of 161.3M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while HYL.BR trades at $5.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas HYL.BR's P/E ratio is -25.04. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to HYL.BR's ROE of -0.19%. Regarding short-term risk, ALNEV.PA is more volatile compared to HYL.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs OSE.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, OSE.PA has a market cap of 132.5M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while OSE.PA trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas OSE.PA's P/E ratio is 4.07. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to OSE.PA's ROE of +0.52%. Regarding short-term risk, ALNEV.PA is more volatile compared to OSE.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALSEN.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALSEN.PA has a market cap of 105.8M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALSEN.PA trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALSEN.PA's P/E ratio is -3.91. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALSEN.PA's ROE of -0.33%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALSEN.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALCLS.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALCLS.PA has a market cap of 99.9M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALCLS.PA trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALCLS.PA's P/E ratio is -2.35. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALCLS.PA's ROE of -0.29%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALCLS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs TNG.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, TNG.PA has a market cap of 87.1M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while TNG.PA trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas TNG.PA's P/E ratio is -2.28. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to TNG.PA's ROE of -4.66%. Regarding short-term risk, ALNEV.PA is more volatile compared to TNG.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs MAAT.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, MAAT.PA has a market cap of 78.3M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while MAAT.PA trades at $4.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas MAAT.PA's P/E ratio is -2.21. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to MAAT.PA's ROE of -1.61%. Regarding short-term risk, ALNEV.PA is more volatile compared to MAAT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ADOC.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ADOC.PA has a market cap of 66.1M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ADOC.PA trades at $3.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ADOC.PA's P/E ratio is -3.66. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ADOC.PA's ROE of +1.28%. Regarding short-term risk, ALNEV.PA is more volatile compared to ADOC.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ERYP.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ERYP.PA has a market cap of 48.7M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ERYP.PA trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ERYP.PA's P/E ratio is -80.10. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ERYP.PA's ROE of -0.73%. Regarding short-term risk, ALNEV.PA is more volatile compared to ERYP.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ABNX.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ABNX.PA has a market cap of 45.8M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ABNX.PA trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ABNX.PA's P/E ratio is -10.15. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ABNX.PA's ROE of -0.52%. Regarding short-term risk, ALNEV.PA is more volatile compared to ABNX.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs VVY.AS Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, VVY.AS has a market cap of 45.3M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while VVY.AS trades at $1.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas VVY.AS's P/E ratio is -2.20. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to VVY.AS's ROE of -1.88%. Regarding short-term risk, ALNEV.PA is more volatile compared to VVY.AS. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALGEN.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALGEN.PA has a market cap of 30.8M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALGEN.PA trades at $3.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALGEN.PA's P/E ratio is 13.44. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALGEN.PA's ROE of +0.10%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALGEN.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs COX.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, COX.PA has a market cap of 29M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while COX.PA trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas COX.PA's P/E ratio is -0.46. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to COX.PA's ROE of -0.43%. Regarding short-term risk, ALNEV.PA is more volatile compared to COX.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs SIGHT.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, SIGHT.PA has a market cap of 27.3M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while SIGHT.PA trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas SIGHT.PA's P/E ratio is -1.40. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to SIGHT.PA's ROE of +0.54%. Regarding short-term risk, ALNEV.PA is more volatile compared to SIGHT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs POXEL.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, POXEL.PA has a market cap of 25.4M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while POXEL.PA trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas POXEL.PA's P/E ratio is -1.18. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to POXEL.PA's ROE of +0.32%. Regarding short-term risk, ALNEV.PA is more volatile compared to POXEL.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs FALG.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, FALG.PA has a market cap of 24M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while FALG.PA trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas FALG.PA's P/E ratio is -2.33. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to FALG.PA's ROE of -0.39%. Regarding short-term risk, ALNEV.PA is more volatile compared to FALG.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs DMSIM.BR Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, DMSIM.BR has a market cap of 23.1M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while DMSIM.BR trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas DMSIM.BR's P/E ratio is 0.09. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to DMSIM.BR's ROE of -0.57%. Regarding short-term risk, ALNEV.PA is more volatile compared to DMSIM.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALDVI.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALDVI.PA has a market cap of 22.9M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALDVI.PA trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALDVI.PA's P/E ratio is -3.88. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALDVI.PA's ROE of +0.44%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALDVI.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALVAL.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALVAL.PA has a market cap of 18.3M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALVAL.PA trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALVAL.PA's P/E ratio is -1.92. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALVAL.PA's ROE of -0.74%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALVAL.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs CYAD.BR Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, CYAD.BR has a market cap of 18.1M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while CYAD.BR trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas CYAD.BR's P/E ratio is -0.32. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to CYAD.BR's ROE of +0.91%. Regarding short-term risk, ALNEV.PA is more volatile compared to CYAD.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs AELIS.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, AELIS.PA has a market cap of 16.7M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while AELIS.PA trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas AELIS.PA's P/E ratio is -2.22. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to AELIS.PA's ROE of -0.74%. Regarding short-term risk, ALNEV.PA is more volatile compared to AELIS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALPHE.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALPHE.PA has a market cap of 15.8M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALPHE.PA trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALPHE.PA's P/E ratio is -2.67. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALPHE.PA's ROE of -0.64%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALPHE.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALNFL.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALNFL.PA has a market cap of 12.3M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALNFL.PA trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALNFL.PA's P/E ratio is -5.76. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALNFL.PA's ROE of -1.27%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALNFL.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALPAT.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALPAT.PA has a market cap of 12.1M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALPAT.PA trades at $10.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALPAT.PA's P/E ratio is 12.95. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALPAT.PA's ROE of +0.01%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALPAT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs BAI.AS Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, BAI.AS has a market cap of 11.2M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while BAI.AS trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas BAI.AS's P/E ratio is -0.13. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to BAI.AS's ROE of -0.51%. Regarding short-term risk, ALNEV.PA is less volatile compared to BAI.AS. This indicates potentially lower risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALVET.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALVET.PA has a market cap of 10M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALVET.PA trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALVET.PA's P/E ratio is -0.17. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALVET.PA's ROE of -0.32%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALVET.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALVIO.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALVIO.PA has a market cap of 9.8M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALVIO.PA trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALVIO.PA's P/E ratio is -0.45. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALVIO.PA's ROE of -2.09%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALVIO.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs APM.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, APM.PA has a market cap of 8.8M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while APM.PA trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas APM.PA's P/E ratio is -0.71. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to APM.PA's ROE of +0.08%. Regarding short-term risk, ALNEV.PA is less volatile compared to APM.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALTME.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALTME.PA has a market cap of 8.5M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALTME.PA trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALTME.PA's P/E ratio is -0.71. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALTME.PA's ROE of -8.99%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALTME.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALTHX.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALTHX.PA has a market cap of 8.3M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALTHX.PA trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALTHX.PA's P/E ratio is -4.67. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALTHX.PA's ROE of +7.08%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALTHX.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALQGC.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALQGC.PA has a market cap of 5M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALQGC.PA trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALQGC.PA's P/E ratio is -0.09. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALQGC.PA's ROE of +14.01%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALQGC.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs LYS.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, LYS.PA has a market cap of 4.9M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while LYS.PA trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas LYS.PA's P/E ratio is -0.64. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to LYS.PA's ROE of -11.30%. Regarding short-term risk, ALNEV.PA is more volatile compared to LYS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALINT.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALINT.PA has a market cap of 4.2M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALINT.PA trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALINT.PA's P/E ratio is -15.90. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALINT.PA's ROE of -0.14%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALINT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALHYG.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALHYG.PA has a market cap of 3.9M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALHYG.PA trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALHYG.PA's P/E ratio is -0.26. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALHYG.PA's ROE of -6.80%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALHYG.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALACT.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALACT.PA has a market cap of 3.9M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALACT.PA trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALACT.PA's P/E ratio is -0.22. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALACT.PA's ROE of +1.38%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALACT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALBPS.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALBPS.PA has a market cap of 2.9M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALBPS.PA trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALBPS.PA's P/E ratio is -0.03. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALBPS.PA's ROE of +1.88%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALBPS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs GNRO.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, GNRO.PA has a market cap of 2.3M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while GNRO.PA trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas GNRO.PA's P/E ratio is -0.13. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to GNRO.PA's ROE of +2.39%. Regarding short-term risk, ALNEV.PA is more volatile compared to GNRO.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALMDP.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALMDP.PA has a market cap of 1.8M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALMDP.PA trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALMDP.PA's P/E ratio is -0.59. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALMDP.PA's ROE of +0.40%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALMDP.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALDEI.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALDEI.PA has a market cap of 1.1M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALDEI.PA trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALDEI.PA's P/E ratio is -0.11. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALDEI.PA's ROE of +0.61%. Regarding short-term risk, ALNEV.PA is less volatile compared to ALDEI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs BIOS.BR Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, BIOS.BR has a market cap of 1.1M. Regarding current trading prices, ALNEV.PA is priced at $0.00, while BIOS.BR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas BIOS.BR's P/E ratio is -0.04. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to BIOS.BR's ROE of +0.34%. Regarding short-term risk, ALNEV.PA is more volatile compared to BIOS.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs OVXA.IR Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, OVXA.IR has a market cap of 856.4K. Regarding current trading prices, ALNEV.PA is priced at $0.00, while OVXA.IR trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas OVXA.IR's P/E ratio is -0.21. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to OVXA.IR's ROE of -0.00%. Regarding short-term risk, ALNEV.PA is more volatile compared to OVXA.IR. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs OXUR.BR Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, OXUR.BR has a market cap of 338.6K. Regarding current trading prices, ALNEV.PA is priced at $0.00, while OXUR.BR trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas OXUR.BR's P/E ratio is N/A. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to OXUR.BR's ROE of -0.01%. Regarding short-term risk, ALNEV.PA is more volatile compared to OXUR.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALPHA.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALPHA.PA has a market cap of 1.2K. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALPHA.PA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALPHA.PA's P/E ratio is -0.00. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALPHA.PA's ROE of +0.83%. Regarding short-term risk, ALNEV.PA is less volatile compared to ALPHA.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ASIT.BR Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ASIT.BR has a market cap of 0. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ASIT.BR trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ASIT.BR's P/E ratio is -32.71. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ASIT.BR's ROE of +0.38%. Regarding short-term risk, ALNEV.PA is more volatile compared to ASIT.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ADVIC.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ADVIC.PA has a market cap of 0. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ADVIC.PA trades at $6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ADVIC.PA's P/E ratio is -3.67. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ADVIC.PA's ROE of +0.44%. Regarding short-term risk, ALNEV.PA is more volatile compared to ADVIC.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALNOX.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALNOX.PA has a market cap of 0. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALNOX.PA trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALNOX.PA's P/E ratio is -0.19. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALNOX.PA's ROE of -2.36%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALNOX.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ACPH.BR Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ACPH.BR has a market cap of 0. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ACPH.BR trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ACPH.BR's P/E ratio is -1.40. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ACPH.BR's ROE of -1.55%. Regarding short-term risk, ALNEV.PA is more volatile compared to ACPH.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs BOTHE.BR Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, BOTHE.BR has a market cap of 0. Regarding current trading prices, ALNEV.PA is priced at $0.00, while BOTHE.BR trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas BOTHE.BR's P/E ratio is -0.38. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to BOTHE.BR's ROE of +7.51%. Regarding short-term risk, ALNEV.PA is less volatile compared to BOTHE.BR. This indicates potentially lower risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALIMM.BR Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALIMM.BR has a market cap of 0. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALIMM.BR trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALIMM.BR's P/E ratio is -2.23. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALIMM.BR's ROE of -0.92%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALIMM.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ALONC.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ALONC.PA has a market cap of 0. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ALONC.PA trades at $14.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ALONC.PA's P/E ratio is 63.25. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ALONC.PA's ROE of -0.09%. Regarding short-term risk, ALNEV.PA is more volatile compared to ALONC.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs GKTX.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, GKTX.PA has a market cap of 0. Regarding current trading prices, ALNEV.PA is priced at $0.00, while GKTX.PA trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas GKTX.PA's P/E ratio is -2.56. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to GKTX.PA's ROE of -2.26%. Regarding short-term risk, ALNEV.PA is more volatile compared to GKTX.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs VLAP.PA Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, VLAP.PA has a market cap of 0. Regarding current trading prices, ALNEV.PA is priced at $0.00, while VLAP.PA trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas VLAP.PA's P/E ratio is -0.10. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to VLAP.PA's ROE of -0.43%. Regarding short-term risk, ALNEV.PA is more volatile compared to VLAP.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.
ALNEV.PA vs ORPH.IR Comparison
ALNEV.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ALNEV.PA stands at 7.5K. In comparison, ORPH.IR has a market cap of 0. Regarding current trading prices, ALNEV.PA is priced at $0.00, while ORPH.IR trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ALNEV.PA currently has a P/E ratio of N/A, whereas ORPH.IR's P/E ratio is N/A. In terms of profitability, ALNEV.PA's ROE is -1.79%, compared to ORPH.IR's ROE of -0.00%. Regarding short-term risk, ALNEV.PA is more volatile compared to ORPH.IR. This indicates potentially higher risk in terms of short-term price fluctuations for ALNEV.PA.